⌘K

Login Start Free

Home/Filings/4/0001600132-20-000102

4//SEC Filing

Moura Andre V. 4

Accession 0001600132-20-000102

CIK 0001600132other

View on SEC.gov Company Profile

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 4:03 PM ET

Size

5.2 KB

Accession

0001600132-20-000102

Insider Transaction Report

Form 4

Period: 2020-09-10

Bellerophon Therapeutics, Inc.BLPH

Director

Transactions

Award
Stock Option (right to buy)
2020-09-10$10.12/sh+6,509$65,871→ 13,472 total
Exercise: $10.12From: 2021-09-10Exp: 2030-09-10→ Common Stock (6,509 underlying)

Documents

1 file

4
wf-form4_160011379465128.xmlPrimary
FORM 4

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1

filerCIK 0001631831

Filing Metadata

Form type: 4
Filed: Sep 13, 8:00 PM ET
Accepted: Sep 14, 4:03 PM ET
Size: 5.2 KB

View on SEC.gov